March 7th 2023
About 60% of dual vapers experienced depression and 52% experienced anxiety, according to findings from a survey of over 2500 youth and young adults.
Current Challenges With MDD Treatment Options
February 2nd 2023Carmen Kosicek, MSN, PMHNP-BC, leads a discussion on the level of satisfaction for both patients and providers with currently available MDD treatment options, barriers to access, and the impact of residual symptoms on a patient’s quality of life.